Why Pharma Company Amarin Shares Are Zooming Today

The company ended 2023 with cash of around $321 million and investments, with a positive cash flow of about $10 million. 

Amarin says it is on track to deliver $40 million of annual savings based on the reduction in force announced in July 2023. 

Share Buyback: Amarin entered into a conditional share repurchase agreement with Cantor Fitzgerald & Co. to buy up to $50 million of its ordinary shares in American depository shares (ADSs). 

Amarin anticipates completing this initiative by the end of Q2 2024, with share repurchases commencing shortly after.

Price Action: AMRN shares are up 28% at $1.24 on the last check Wednesday. 

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.